Skip to main content

Advertisement

ADVERTISEMENT

News

Drug-Coated Balloons
10/27/2024
The SirPlux Duo DCB is designed to deliver sirolimus and paclitaxel simultaneously to inhibit cell growth at a higher potency and efficient dose.
The SirPlux Duo DCB is designed to deliver sirolimus and paclitaxel simultaneously to inhibit cell growth at a higher potency and efficient dose.
The SirPlux Duo DCB is designed...
10/27/2024
Cath Lab Digest
The initial cases of Adona Medical's adjustable interatrial shunt for heart failure were conducted in the Republic of Georgia led by Dr. George Khabeishvili and supported by US experts Dr. Gagan Singh, Dr. Edris Aman and the Adona Medical team.
heart failure
10/27/2024
The Adona device includes a shunt that features a flow channel with an adjustable geometry that can be made larger or smaller post-implantation via the use of a proprietary induction catheter.
The Adona device includes a shunt that features a flow channel with an adjustable geometry that can be made larger or smaller post-implantation via the use of a proprietary induction catheter.
The Adona device includes a...
10/27/2024
Cath Lab Digest

Advertisement

Imaging & Physiology
10/27/2024
HeartFlow News WASHINGTON -- HeartFlow, Inc. announced seven-year data confirming the use of HeartFlow’s AI-enabled fractional flow reserve computed tomography (FFRCT) and Plaque Analysis in the assessment of long-term risk of...
HeartFlow News WASHINGTON -- HeartFlow, Inc. announced seven-year data confirming the use of HeartFlow’s AI-enabled fractional flow reserve computed tomography (FFRCT) and Plaque Analysis in the assessment of long-term risk of...
HeartFlow News WASHINGTON...
10/27/2024
Cath Lab Digest
plaque analysis
10/25/2024
With this decision, five of the seven Medicare Administrative Contractors (MACs) will soon provide coverage for AI-enabled quantitative coronary plaque analysis, expanding accessibility to over 70 percent of eligible Medicare patients across...
With this decision, five of the seven Medicare Administrative Contractors (MACs) will soon provide coverage for AI-enabled quantitative coronary plaque analysis, expanding accessibility to over 70 percent of eligible Medicare patients across...
With this decision, five of the...
10/25/2024
Cath Lab Digest
Pulmonary Embolism
10/25/2024
“The unique maneuverability of the large-bore Vertex endoportal device enabled us to easily navigate across multiple bends through the right heart and into the pulmonary arteries," said Mitchell Weinberg, MD.
“The unique maneuverability of the large-bore Vertex endoportal device enabled us to easily navigate across multiple bends through the right heart and into the pulmonary arteries," said Mitchell Weinberg, MD.
“The unique maneuverability of...
10/25/2024
Cath Lab Digest

Advertisement

Aortic Valve Stenosis
10/25/2024
The latest Evolut FX+ TAVI system offers three larger coronary access windows through a modified diamond-shaped frame design, which are four times larger than regular cells of the Evolut TAVI system.
The latest Evolut FX+ TAVI system offers three larger coronary access windows through a modified diamond-shaped frame design, which are four times larger than regular cells of the Evolut TAVI system.
The latest Evolut FX+ TAVI...
10/25/2024
Cath Lab Digest
A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function.  Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest

Advertisement

CABG
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
10/21/2024
MedAxiom has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of programs since its debut. The report features a foreword from MedAxiom President and CEO Jerry...
MedAxiom has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of programs since its debut. The report features a foreword from MedAxiom President and CEO Jerry...
MedAxiom has released its 2024...
10/21/2024
Cath Lab Digest

Advertisement